dc.contributor.author | Graham, Michelle M. | |
dc.contributor.author | Sessler, Daniel I. | |
dc.contributor.author | Parlow, Joel L. | |
dc.contributor.author | Biccard, Bruce M. | |
dc.contributor.author | Guyatt, Gordon | |
dc.contributor.author | Leslie, Kate | |
dc.contributor.author | Chan, Matthew T. V. | |
dc.contributor.author | Meyhoff, Christian S. | |
dc.contributor.author | Xavier, Denis | |
dc.contributor.author | Sigamani, Alben | |
dc.contributor.author | Kumar, Priya A. | |
dc.contributor.author | Mrkobrada, Marko | |
dc.contributor.author | Cook, Deborah J. | |
dc.contributor.author | Tandon, Vikas | |
dc.contributor.author | Alvarez-Garcia, Jesus | |
dc.contributor.author | Villar, Juan Carlos | |
dc.contributor.author | Painter, Thomas W. | |
dc.contributor.author | Landoni, Giovanni | |
dc.contributor.author | Fleischmann, Edith | |
dc.contributor.author | Lamy, Andre | |
dc.contributor.author | Whitlock, Richard | |
dc.contributor.author | Le Manach, Yannick | |
dc.contributor.author | Aphang-Lam, Meylin | |
dc.contributor.author | Cata, Juan P. | |
dc.contributor.author | Gao, Peggy | |
dc.contributor.author | Terblanche, Nicolaas C. S. | |
dc.contributor.author | Ramana, Pamidimukkala V. | |
dc.contributor.author | Jamieson, Kim A. | |
dc.contributor.author | Bessissow, Amal | |
dc.contributor.author | Mendoza, Gabriela R. | |
dc.contributor.author | Ramirez, Silvia | |
dc.contributor.author | Diemunsch, Pierre A. | |
dc.contributor.author | Yusuf, Salim | |
dc.contributor.author | Devereaux, P. J. | |
dc.date.accessioned | 2018-11-30T02:09:29Z | |
dc.date.available | 2018-11-30T02:09:29Z | |
dc.date.issued | 2018 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/4003 | |
dc.description.abstract | Background: Uncertainty remains about the effects of aspirin in patients with prior percutaneous coronary intervention (PCI) having noncardiac surgery. Objective: To evaluate benefits and harms of perioperative aspirin in patients with prior PCI. Design: Nonprespecified subgroup analysis of a multicenter factorial trial. Computerized Internet randomization was done between 2010 and 2013. Patients, clinicians, data collectors, and outcome adjudicators were blinded to treatment assignment. (ClinicalTrials.gov: NCT01082874). Setting: 135 centers in 23 countries. Patients: Adults aged 45 years or older who had or were at risk for atherosclerotic disease and were having noncardiac surgery. Exclusions were placement of a bare-metal stent within 6 weeks, placement of a drug-eluting stent within 1 year, or receipt of nonstudy aspirin within 72 hours before surgery. Intervention: Aspirin therapy (overall trial, n = 4998; subgroup, n = 234) or placebo (overall trial, n = 5012; subgroup, n = 236) initiated within 4 hours before surgery and continued throughout the perioperative period. Of the 470 subgroup patients, 99.9% completed follow-up. Measurements: The 30-day primary outcome was death or nonfatal myocardial infarction; bleeding was a secondary outcome. Results: In patients with prior PCI, aspirin reduced the risk for the primary outcome (absolute risk reduction, 5.5% [95% CI, 0.4% to 10.5%]; hazard ratio [HR], 0.50 [CI, 0.26 to 0.95]; P for interaction = 0.036) and for myocardial infarction (absolute risk reduction, 5.9% [CI, 1.0% to 10.8%]; HR, 0.44 [CI, 0.22 to 0.87]; P for interaction = 0.021). The effect on the composite of major and life-threatening bleeding in patients with prior PCI was uncertain (absolute risk increase, 1.3% [CI, -2.6% to 5.2%]). In the overall population, aspirin increased the risk for major bleeding (absolute risk increase, 0.8% [CI, 0.1% to 1.6%]; HR, 1.22 [CI, 1.01 to 1.48]; P for interaction = 0.50). Limitation: Nonprespecified subgroup analysis with small sample. Conclusion: Perioperative aspirin may be more likely to benefit rather than harm patients with prior PCI. | en_US |
dc.language.iso | eng | |
dc.publisher | American College of Physicians | |
dc.relation.ispartofseries | Annals of Internal Medicine | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | Absolute risk reduction | en_US |
dc.subject | Aspirin | en_US |
dc.subject | Drugs | en_US |
dc.subject | Hazard ratio | en_US |
dc.subject | Hemorrhage | en_US |
dc.subject | Hospital medicine | en_US |
dc.subject | Myocardial infarction | en_US |
dc.subject | Percutaneous coronary intervention | en_US |
dc.subject | Stent implantation | en_US |
dc.subject | Surgery | en_US |
dc.title | Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.7326/M17-2341 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.02.27 | |
dc.relation.issn | 1539-3704 |
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |